Results 51 to 60 of about 373,212 (300)

Mixed phase activated artificial muscle

open access: yesJournal of Advanced Mechanical Design, Systems, and Manufacturing, 2018
This article presents the mixed phase as the pressure medium of hydraulic artificial muscles, which has rarely been mentioned before. Then a novel mixed phase activated artificial muscle is designed.
Wanda ZHAO   +5 more
doaj   +1 more source

Plant‐Like Tropisms in Artificial Muscles

open access: yesAdvanced Materials, 2023
Helical plants have the ability of tropisms to respond to natural stimuli, and biomimicry of such helical shapes into artificial muscles has been vastly popular. However, the shape‐mimicked actuators only respond to artificially provided stimulus, they are not adaptive to variable natural conditions, thus being unsuitable for real‐life applications ...
Shazed Aziz   +5 more
openaire   +3 more sources

Aggressive prostate cancer is associated with pericyte dysfunction

open access: yesMolecular Oncology, EarlyView.
Tumor‐produced TGF‐β drives pericyte dysfunction in prostate cancer. This dysfunction is characterized by downregulation of some canonical pericyte markers (i.e., DES, CSPG4, and ACTA2) while maintaining the expression of others (i.e., PDGFRB, NOTCH3, and RGS5).
Anabel Martinez‐Romero   +11 more
wiley   +1 more source

Fluid muscle behavior determination [PDF]

open access: yes, 2014
Táto práca sa zaoberá zistením základných charakteristík pneumatického umelého svalu PAM (Pneumatic artificial muscle) firmy Festo, programovaním knižnice prvkov v prostredí LabVIEW pre proporcionálne ovládanie ventilu, návrhom a zostrojením stanice pre ...
Szente, Michal
core  

A prospective analysis of the injury incidence of young male professional football players on artificial turf [PDF]

open access: yes, 2016
Background: The effects of synthetic surfaces on the risk of injuries is still debated in literature and the majority of published data seems to be contradictory.
Arnason A   +11 more
core   +2 more sources

Improving PARP inhibitor efficacy in bladder cancer without genetic BRCAness by combination with PLX51107

open access: yesMolecular Oncology, EarlyView.
Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz   +15 more
wiley   +1 more source

Potential therapeutic targeting of BKCa channels in glioblastoma treatment

open access: yesMolecular Oncology, EarlyView.
This review summarizes current insights into the role of BKCa and mitoBKCa channels in glioblastoma biology, their potential classification as oncochannels, and the emerging pharmacological strategies targeting these channels, emphasizing the translational challenges in developing BKCa‐directed therapies for glioblastoma treatment.
Kamila Maliszewska‐Olejniczak   +4 more
wiley   +1 more source

Finger Prosthesis Driven by DEA Pairs as Agonist–Antagonist Artificial Muscles

open access: yesBiomimetics
Loss of an upper limb exerts a negative influence on an individual’s ability to perform their activities of daily living (ADLs), reducing quality of life and self-esteem.
Alexandre B. S. da Silva   +5 more
doaj   +1 more source

Effects and Solutions on the Human Body After Long-Duration Space Flights [PDF]

open access: yes, 2019
During the Cold War, President John F. Kennedy made it a mission for the National Aeronautics and Space Administration (NASA) to accomplish a lunar landing and return to Earth.
Esquivel Patricio, Jose Jaime
core   +1 more source

Dammarenediol II enhances etoposide‐induced apoptosis by targeting O‐GlcNAc transferase and Akt/GSK3β/mTOR signaling in liver cancer

open access: yesMolecular Oncology, EarlyView.
Etoposide induces DNA damage, activating p53‐dependent apoptosis via caspase‐3/7, which cleaves PARP1. Dammarenediol II enhances this apoptotic pathway by suppressing O‐GlcNAc transferase activity, further decreasing O‐GlcNAcylation. The reduction in O‐GlcNAc levels boosts p53‐driven apoptosis and influences the Akt/GSK3β/mTOR signaling pathway ...
Jaehoon Lee   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy